Fact CheckerSign in

NCT06295848Completed

The Effects of Cardiac Rehabilitation Programme in Hypertensive Rheumatoid Arthritis Patients

The Effects of 6-week Cardiac Rehabilitation Programme on Cardiovascular Disease Risk, Systolic and Diastolic Blood Pressure and Disease Activity in Hypertensive Rheumatoid Arthritis Patients : A Randomised Controlled Trial

Source: ClinicalTrials.gov · Last updated 18 Jun 2026

Brief summary (registry, in English)

The aim of this study is to investigate the beneficial impacts of the 6-week standardized CR program applied to hypertensive RA patients whose disease activity is under control with regular pharmacological treatment. Subjects will be randomly assigned to one of two groups: 1.) standard of care (SOC) treatment or 2.) SOC plus a 6 week CR program.

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
1 Sept 2023
Start date
15 Nov 2022
Primary completion date
15 Apr 2024
Lead sponsor
Kayseri City Hospital
NCT number
NCT06295848

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 15 Nov 2022 to the primary completion date, 15 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe mental disorder
  • Neurological disease or deformity in the lower extremity that would prevent the patient from using the treadmill.
  • High-risk unstable angina and all acute cardiac diseases (acute myocardial infarction, acute endocarditis, myocarditis or pericarditis)
  • Uncontrolled HT, Diabetes, cardiac arrhythmia and heart failure
  • Acute pulmonary embolism or pulmonary infarction and severe pulmonary hypertension

Other

  • Refusing to participate in the program
  • Symptomatic severe aortic stenosis

Who the study is looking for

  • Patients diagnosed with RA according to ACR/EULAR 2010 criteria
  • Taking regular treatment for at least 1 month according to ACR/EULAR guidelines
  • Patients diagnosed with HT according to the 2018 European Society of Hypertension and European Society of Cardiology (ESH/ESC) guideline

Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
health sciences university Kayseri medicine faculty
Coordinator of this site? Confirm its status
KayseriTurkey (Türkiye)Unknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.